We conducted a study to determine whether taking HMG-CoA reductase inhibitors (statins) before percutaneous coronary intervention (PCI) would prevent an increase in cardiac enzyme levels after the procedure. Results showed that statin treatment reduced the rate of increased cardiac enzyme levels and therefore periprocedural cardiac injury following PCI.
|Number of pages||4|
|Publication status||Published - Dec 2005|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine